Prolyl endopeptidase-mediated destruction of T cell epitopes in whole gluten: Chemical and immunological characterization

被引:102
作者
Marti, T
Molberg, O
Li, Q
Gray, GM
Khosla, C
Sollid, LM
机构
[1] Celiac Sprue Res Fdn, Palo Alto, CA 94304 USA
[2] Univ Oslo, Rikshosp, Inst Immunol, N-0027 Oslo, Norway
关键词
D O I
10.1124/jpet.104.073312
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Celiac Sprue is a widely prevalent immune disease of the small intestine induced by dietary gluten intake in genetically susceptible individuals. It has been suggested that prolyl endopeptidases (PEPs) may be useful catalysts for gluten detoxification. We have investigated this hypothesis using food-grade gluten as the target antigen, and a combination of mass spectrometry and patient-derived T cells as quantitative assay systems. Spectrometric characterization of physiologically proteolyzed gluten revealed a number of 10 to 50 residue peptides containing known T cell epitopes involved in Celiac Sprue pathogenesis. Several of these peptides were multivalent, suggesting they may be potent triggers of the inflammatory response to gluten in celiac patients. Treatment of proteolyzed gluten with recombinant bacterial PEP decreased the number of potentially immunostimulatory peptides. Substantially reduced immunogenicity was also quantified in 12 of 14 intestinal polyclonal T cell lines from celiac patients. Kinetic investigations using eight T cell clones showed rapid destruction of alpha-gliadin epitopes, but less complete processing of gamma-gliadin epitopes. Given the difficulty associated with a strict lifelong gluten-exclusion diet, the ability of a single enzyme to greatly reduce the antigenic burden of grocery store gluten reinforces the case for developing oral peptidase therapy against Celiac Sprue.
引用
收藏
页码:19 / 26
页数:8
相关论文
共 23 条
[1]   The intestinal T cell response to α-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase [J].
Arentz-Hansen, H ;
Körner, R ;
Molberg, O ;
Quarsten, H ;
Vader, W ;
Kooy, YMC ;
Lundin, KEA ;
Koning, F ;
Roepstorff, P ;
Sollid, LM ;
McAdam, SN .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (04) :603-612
[2]   Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues [J].
Arentz-Hansen, H ;
McAdam, SN ;
Molberg, O ;
Fleckenstein, B ;
Lundin, KEA ;
Jorgensen, TJD ;
Jung, G ;
Roepstorff, P ;
Sollid, LM .
GASTROENTEROLOGY, 2002, 123 (03) :803-809
[3]   Identification of tissue transglutaminase as the autoantigen of celiac disease [J].
Dieterich, W ;
Ehnis, T ;
Bauer, M ;
Donner, P ;
Volta, U ;
Riecken, EO ;
Schuppan, D .
NATURE MEDICINE, 1997, 3 (07) :797-801
[4]   Current concepts - Celiac sprue [J].
Farrell, RJ ;
Kelly, CP .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (03) :180-188
[5]   Coeliac disease [J].
Green, PHR ;
Jabri, B .
LANCET, 2003, 362 (9381) :383-391
[6]   Quantitative analysis of complex protein mixtures using isotope-coded affinity tags [J].
Gygi, SP ;
Rist, B ;
Gerber, SA ;
Turecek, F ;
Gelb, MH ;
Aebersold, R .
NATURE BIOTECHNOLOGY, 1999, 17 (10) :994-999
[7]   Intestinal digestive resistance of immunodominant gliadin peptides [J].
Hausch, F ;
Shan, L ;
Santiago, NA ;
Gray, GM ;
Khosla, C .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2002, 283 (04) :G996-G1003
[8]   Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease [J].
Maiuri, L ;
Ciacci, C ;
Ricciardelli, I ;
Vacca, L ;
Raia, V ;
Auricchio, S ;
Picard, J ;
Osman, M ;
Quaratino, S ;
Londei, M .
LANCET, 2003, 362 (9377) :30-37
[9]   Prevalence of celiac disease among children in Finland [J].
Maki, M ;
Mustalahti, K ;
Kokkonen, J ;
Kulmala, P ;
Haapalahti, M ;
Karttunen, T ;
Ilonen, J ;
Laurila, K ;
Dahlbom, I ;
Hansson, T ;
Hopfl, P ;
Knip, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (25) :2517-2524
[10]   Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease [J].
Molberg, O ;
Mcadam, SN ;
Körner, R ;
Quarsten, H ;
Kristiansen, C ;
Madsen, L ;
Fugger, L ;
Scott, H ;
Norén, O ;
Roepstorff, P ;
Lundin, KEA ;
Sjöström, H ;
Sollid, LM .
NATURE MEDICINE, 1998, 4 (06) :713-717